Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Eliza J. McEwin"'
Autor:
Ray Moynihan, Peter Fox, Lisa A Bero, Barbara Mintzes, Eliza J McEwin, Adrian M J Pokorny, Deme J Karikios
Publikováno v:
BMJ Open, Vol 13, Iss 5 (2023)
Objectives To understand how and why Australian cancer physicians interact with the pharmaceutical industry.Design Qualitative study using semistructured interviews, performed by a medical oncologist. Thematic analysis using a combination of deductiv
Externí odkaz:
https://doaj.org/article/4507fbea3d454da98871890e0e62cab4
Autor:
Adrian M J Pokorny, Lisa A Bero, Peter Fox, Deme J Karikios, Eliza J McEwin, Ray Moynihan, Barbara Mintzes
Publikováno v:
BMJ Open. 13:e065719
ObjectivesTo understand how and why Australian cancer physicians interact with the pharmaceutical industry.DesignQualitative study using semistructured interviews, performed by a medical oncologist. Thematic analysis using a combination of deductive
Publikováno v:
Critical Public Health. 32:309-321
Full-body computed tomography (CT) screening came to Australia in 2002. Within a year, public access to self-referred full-body CT screening was withdrawn as a consequence of sustained professional...
Autor:
Barbara Mintzes, Mathias Møllebæk, Nileesa Gautam, Alice Bhasale, Ameet Sarpatwari, Eliza J. McEwin, Wendy Lipworth, Adrian J. Santiago Ortiz
Publikováno v:
British Journal of Clinical Pharmacology
Aims Medicines regulators issue post-market safety warnings to advise of newly uncovered risks, but with mixed impacts. We aimed to identify factors influencing the use of regulatory warnings by primary care and specialist physicians in the US and Au
Autor:
Annim Mohammad, Barbara Mintzes, Alice Bhasale, Lucy T. Perry, Eliza J. McEwin, Alice Fabbri, Ashleigh Hooimeyer
Publikováno v:
Pharmacology Research & Perspectives
Hooimeyer, A, Bhasale, A, Perry, L, Fabbri, A, Mohammad, A, McEwin, E & Mintzes, B 2020, ' Regulatory post-market drug safety advisories on cardiac harm : A comparison of four national regulatory agencies ', Pharmacology Research & Perspectives, vol. 8, no. 6, e00680 . https://doi.org/10.1002/prp2.680
Pharmacology Research & Perspectives, Vol 8, Iss 6, Pp n/a-n/a (2020)
Hooimeyer, A, Bhasale, A, Perry, L, Fabbri, A, Mohammad, A, McEwin, E & Mintzes, B 2020, ' Regulatory post-market drug safety advisories on cardiac harm : A comparison of four national regulatory agencies ', Pharmacology Research & Perspectives, vol. 8, no. 6, e00680 . https://doi.org/10.1002/prp2.680
Pharmacology Research & Perspectives, Vol 8, Iss 6, Pp n/a-n/a (2020)
Information on rare adverse effects is often limited when a medication is initially approved for marketing. Medicines regulators use safety advisories to warn health professionals and consumers about emerging harms. This study aimed to identify chara
Publikováno v:
Oral presentations.
Objectives Full body computed tomography (CT) scans for screening came to Australia in 2002, accompanied by a wave of advertising promising life-changing benefits without disclosing equally life-changing potential harms. Within a year, public access